Exposed to Contaminated Insulin Pens?

By Rheingold Giuffra Ruffo & Plotkin LLP

Olean General Hospital in Cattaraugus County, New York, announced last month that it exposed up to 2,000 patients from 2009 through 2013 to various funguses, viruses, and bacteria because of the reuse of insulin pens. Among the diseases specifically mentioned by the warning as possibly being transmitted are HIV, Hepatitis B, and Hepatitis C.

Our firm represents a patient who died allegedly as a result of a fungal infection which developed after receiving insulin pen injections at the local health care facility. Our firm is highly experienced in handling cases for contamination of medical products. We do not charge for an evaluation and only get paid in the event of a settlement or verdict.

The FDA has warned for several years against the reuse of insulin pens because infections can be transmitted between patients through cross contamination. Despite these warnings, the local facility continued to reuse insulin pens and subjected its patients to the risk of infection with life threatening diseases and infections.

We are familiar with the FDA’s guidelines for testing and diagnosis.

Related Posts